Search

Scott Tabakman Phones & Addresses

  • Redwood City, CA
  • San Diego, CA
  • 398 Cherry St, Bedford Hills, NY 10507 (914) 666-2101
  • Palo Alto, CA
  • 146 Fields Cir, Chapel Hill, NC 27516 (919) 960-2915
  • Katonah, NY
  • Saratoga Springs, NY
  • Gansevoort, NY
  • Newburgh, NY

Work

Company: Private research company Apr 2012 Position: Senior scientist

Education

Degree: PhD School / High School: Stanford University 2006 to 2011 Specialities: Chemistry / Biotechnology

Skills

Confocal Microscopy • Western Blotting • Elisa • Molecular Biology • Flow Cytometry • Fluorescence • Cell Culture • Tissue Culture • Afm • Fluorescence Microscopy • Uv/Vis • Microscopy • Hplc • Dna • Rt Pcr • Sem • Mri • Spr • Nmr • Gel Electrophoresis

Industries

Biotechnology

Resumes

Resumes

Scott Tabakman Photo 1

Senior Scientist

View page
Location:
59 North St, Katonah, NY 10536
Industry:
Biotechnology
Work:
Private Research Company since Apr 2012
Senior Scientist

Halcyon Molecular - Redwood City, CA Jun 2011 - Mar 2012
Research Scientist

American Red Cross Aug 2007 - Jul 2011
Instructor

Stanford University Jul 2006 - Jul 2011
Graduate Student (PhD)

New York University Jun 2005 - Aug 2005
Summer Undergraduate Research Intern
Education:
Stanford University 2006 - 2011
PhD, Chemistry / Biotechnology
Duke University 2002 - 2006
BS, Chemistry, Physics (minor)
Skills:
Confocal Microscopy
Western Blotting
Elisa
Molecular Biology
Flow Cytometry
Fluorescence
Cell Culture
Tissue Culture
Afm
Fluorescence Microscopy
Uv/Vis
Microscopy
Hplc
Dna
Rt Pcr
Sem
Mri
Spr
Nmr
Gel Electrophoresis

Publications

Us Patents

Fluorescence Enhancing Plasmonic Nanoscopic Gold Films And Assays Based Thereon

View page
US Patent:
20130172207, Jul 4, 2013
Filed:
Dec 27, 2012
Appl. No.:
13/728798
Inventors:
The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA, US
Scott M. Tabakman - Palo Alto CA, US
Guosong Hong - Stanford CA, US
Bo Zhang - Stanford CA, US
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
International Classification:
G01N 33/553
US Classification:
506 9, 506 15, 506 18, 506 16, 506 19, 506 30
Abstract:
Disclosed are nanostructured gold films which may be produced by solution-phase depositions of gold ions onto a variety of surfaces. The resulting plasmonic gold films are used for enhanced spectroscopic-based immunoassays in multiplexed microarray format with detection mechanisms based on either surface-enhanced Raman scattering or near-infrared fluorescence enhancement. The preparation of the films and subsequent modifications of the gold film surfaces afford increased sensitivity for various microarrays. The films are discontinuous, forming gold “islands.” Sensitivity, size, shape, and density of the nanoscopic gold islands comprising the discontinuous nanostructured gold film are controlled to enhance the intensity of Raman scattering and fluorescence in the near-infrared, allowing for improved measurements in clinical diagnostic or biomedical research applications.

Proton-Binding Polymers For Oral Administration

View page
US Patent:
20220339186, Oct 27, 2022
Filed:
Apr 19, 2022
Appl. No.:
17/724105
Inventors:
- South San Francisco CA, US
Eric F. CONNOR - Los Gatos CA, US
Randi K. GBUR - Brisbane CA, US
Matthew J. KADE - Berkeley CA, US
Paul H. KIERSTEAD - Oakland CA, US
Jerry M. BUYSSE - Los Altos CA, US
Michael J. COPE - Berkeley CA, US
Kalpesh N. BIYANI - Dublin CA, US
Son H. NGUYEN - Milpitas CA, US
Scott M. TABAKMAN - Palo Alto CA, US
International Classification:
A61K 31/785
C08F 8/02
C08F 226/02
C08F 26/02
Abstract:
Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons and/or chloride ions from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.

Crosslinked Poly(Allylamine) Polymer Pharmaceutical Compositions

View page
US Patent:
20210347925, Nov 11, 2021
Filed:
Jan 11, 2021
Appl. No.:
17/145523
Inventors:
- South San Francisco CA, US
Eric F. CONNOR - Los Gatos CA, US
Randi K. GBUR - Brisbane CA, US
Matthew J. KADE - Berkeley CA, US
Paul H. KIERSTEAD - Oakland CA, US
Kalpesh N. BIYANI - Dublin CA, US
Son H. NGUYEN - Milpitas CA, US
Scott M. TABAKMAN - Palo Alto CA, US
International Classification:
C08F 226/02
A61K 31/785
Abstract:
Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of a target species from the gastrointestinal tract would provide physiological benefits.

Nucleic Acid Amplification

View page
US Patent:
20210332400, Oct 28, 2021
Filed:
Oct 3, 2019
Appl. No.:
16/592707
Inventors:
- Healdsburg CA, US
Josephine Lee - Hayward CA, US
Pranav Patel - Fremont CA, US
Aaron Richardson - Palo Alto CA, US
Scott Tabakman - Palo Alto CA, US
International Classification:
C12P 19/34
C12Q 1/686
Abstract:
Methods and compositions for the amplification of nucleic acids and generation of concatemers are disclosed. Amplification methods provided herein may be performed under isothermal conditions. Methods and compositions may include reagents such as nucleic acid polymerases and primers.

Compositions For Treating Acid-Base Disorders

View page
US Patent:
20210205351, Jul 8, 2021
Filed:
Mar 4, 2021
Appl. No.:
17/192701
Inventors:
- South San Francisco CA, US
Eric F. CONNOR - Los Gatos CA, US
Randi K. GBUR - Brisbane CA, US
Matthew J. KADE - Berkeley CA, US
Paul H. KIERSTEAD - Oakland CA, US
Jerry M. BUYSSE - Los Altos CA, US
Michael J. COPE - Berkeley CA, US
Kalpesh N. BIYANI - Dublin CA, US
Son H. NGUYEN - Milpitas CA, US
Scott M. TABAKMAN - Palo Alto CA, US
International Classification:
A61K 31/785
C08F 8/02
A61K 9/14
A61K 33/00
A61P 43/00
A61P 13/12
A61K 9/00
A61P 3/12
Abstract:
Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain nonabsorbable compositions and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons, the conjugate base of a strong acid and/or a strong acid from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.

Hybrid Multi-Step Nucleic Acid Amplification

View page
US Patent:
20210147910, May 20, 2021
Filed:
Oct 29, 2020
Appl. No.:
17/083815
Inventors:
- Healdsburg CA, US
Indira Wu - San Jose CA, US
Aaron Richardson - Palo Alto CA, US
Zahra Kamila Belhocine - Fremont CA, US
Josephine Lee - Hayward CA, US
Scott Tabakman - Palo Alto CA, US
International Classification:
C12Q 1/686
C12Q 1/6806
Abstract:
Improved methods for amplifying target nucleic acid sequences are provided by 1) first amplifying the number of copies of target nucleic acid sequences in a sample by a first nucleic acid amplification method, and then 2) applying a second nucleic amplification method to the amplified sample, or aliquot thereof, further amplifying the number of copies of target sequences. In embodiments, a first nucleic acid amplification method is a thermocycling method, and a second nucleic acid amplification method is an isothermal method.

Crosslinked Poly(Allylamine) Polymer Pharmaceutical Compositions

View page
US Patent:
20210079144, Mar 18, 2021
Filed:
Sep 21, 2018
Appl. No.:
16/138932
Inventors:
- South San Francisco CA, US
Eric F. CONNOR - Los Gatos CA, US
Randi K. GBUR - Brisbane CA, US
Matthew J. KADE - Berkeley CA, US
Paul H. KIERSTEAD - Oakland CA, US
Kalpesh N. BIYANI - Dublin CA, US
Son H. NGUYEN - Milpitas CA, US
Scott M. TABAKMAN - Palo Alto CA, US
International Classification:
C08F 226/02
A61K 31/785
Abstract:
Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of a target species from the gastrointestinal tract would provide physiological benefits.

Nucleic Acid Amplification

View page
US Patent:
20210024987, Jan 28, 2021
Filed:
Aug 6, 2020
Appl. No.:
16/986557
Inventors:
- Healdsburg CA, US
Josephine Lee - Hayward CA, US
Pranav Patel - Fremont CA, US
Aaron Richardson - Palo Alto CA, US
Scott Tabakman - Palo Alto CA, US
International Classification:
C12Q 1/6844
C12P 19/34
C12Q 1/686
C07H 1/00
Abstract:
Methods and compositions for the amplification of nucleic acids and generation of concatemers are disclosed. Amplification methods provided herein may be performed under isothermal conditions. Methods and compositions may include reagents such nucleic acid polymerases and primers.
Scott M Tabakman from Redwood City, CA, age ~39 Get Report